Increasing Incidence of Gonorrhea to Create Opportunities for the Global Gonorrhea Diagnostics Market Through 2020, Reports Technavio

LONDON--()--Technavio analysts forecast the global gonorrhea diagnostics market to grow at a CAGR of over 9% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global gonorrhea diagnostics market for 2016-2020. The report also mentions new technologies that provide accurate and faster detection of gonorrhea infection. It is predicted that these technologies will surpass conventional procedures so as to completely change the gonorrhea diagnostic market scenario during the forecast period.

Technavio healthcare and life sciences analysts highlight the following four factors that are contributing to the growth of the global gonorrhea diagnostics market:

  • Increase in incidence of gonorrhea
  • Significant growth in emerging countries
  • Increase in patient awareness
  • Improvement in healthcare infrastructure

Increase in incidence of gonorrhea

The incidence of gonorrhea has been on the rise worldwide. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. In 2014, as per the estimates by CDC, there were around 350,062 reported cases of gonorrhea in the US.

The highest incidence of gonorrhea was observed in heterosexually infected men, especially those aged between 25-34 years. During the last 10 years, women constituted only around 20%-30% of all the reported cases of gonorrhea. “The recent increase in gonorrhea cases worldwide is most likely due to the adoption of risky sexual behavior such as increased sexual involvement with multiple partners and unsafe sexual practices. Hence, the increase in incidence of gonorrhea will enhance the demand for gonorrhea diagnostic products,” says Barath Palada, a lead analyst at Technavio for in-vitro diagnostics research.

Significant growth in emerging countries

Several global gonorrhea diagnostic products manufacturers are focusing on expanding in BRIC countries. Implementation of a significant number of government initiatives to build healthcare infrastructure, increased healthcare budgets, and technological advancements are driving the market in these countries. In addition, BRICS is considered to represent an attractive market for MNCs in the healthcare industry, owing to the increase in awareness among consumers about the diagnosis of gonorrhea and approaches to prevent the disease.

Increase in patient awareness

Increase in patient awareness such as education campaigns and growing government initiatives are anticipated to drive the market. Emerging countries such as India, China, and some Latin American countries are focusing on improving the healthcare conditions of their citizens. Many vendors are currently concentrating on expanding their businesses in these emerging countries.

Growing public awareness and a rise in disposable income have increased the demand for gonorrhea diagnostics in the market. In addition, the governments of emerging countries are funding small and medium-sized companies to develop advanced devices. All these factors are expected to help in the increased use of sophisticated gonorrhea diagnosis by physicians and people.

Improvement in healthcare infrastructure

Many countries lack observation systems for healthcare-associated infections, and those that have facilities may often struggle with a lack of standard guidelines and the complexity of diagnosing diseases. In most developed countries, at any given time, the prevalence of healthcare-associated infections varies from 3.5% to 12%. In low and middle-income countries, the prevalence varies from 5.7% to 19.1%. According to a CDC report, the average prevalence rate of hospital acquired infections is 7.1% in Europe.

The government of China implemented reforms in the healthcare sector to provide universal access to healthcare and improve the affordability of services for the country's 1.3 billion people by 2020. Similarly, in India, total healthcare infrastructure spending for 2013 was estimated to exceed USD 14 billion. “The improvement in the healthcare infrastructure will increase the demand for gonorrhea treatment and the patient base, especially in rural areas,” says Barath.

Browse Related Reports:

Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact enquiry@technavio.com with your requirements and our analysts will be happy to create a customized report just for you.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio analysts forecast the global gonorrhea diagnostics market to grow at a CAGR of over 9% during the forecast period, according to their latest report.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com